Cara Therapeutics Inc. sell StockNews.com
Start price
17.02.24
/
50%
€0.54
Target price
17.02.25
-
Performance (%)
-25.51%
End price
18.02.25
-
Summary
This prediction is currently being closed. The price of Cara Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.51%. StockNews_com has a follow-up prediction for Cara Therapeutics Inc. where he still thinks Cara Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cara Therapeutics Inc. | - | - | - |
iShares Core DAX® | -1.740% | -1.152% | 26.268% |
iShares Nasdaq 100 | -0.157% | -0.813% | 15.022% |
iShares Nikkei 225® | -1.705% | 3.309% | 3.092% |
iShares S&P 500 | 0.148% | 0.240% | 10.503% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten